Full text
38,358 characters
· extracted from
preprint-html
· click to expand
Characterizing Plasmodium falciparum genetic diversity and complexity of infections in clinical malaria infections in Western and Coastal Kenya using the poly-alpha microsatellite marker | bioRxiv /* */ /* */ <!-- <!-- /*! * yepnope1.5.4 * (c) WTFPL, GPLv2 */ (function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548'); Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results Characterizing Plasmodium falciparum genetic diversity and complexity of infections in clinical malaria infections in Western and Coastal Kenya using the poly-alpha microsatellite marker Nicole Achieng’ , View ORCID Profile Kelvin M. Kimenyi , Cavin Mgawe , Leonard Ndwiga , View ORCID Profile L. Isabella Ochola-Oyier doi: https://doi.org/10.1101/2025.04.26.650801 Nicole Achieng’ 1 Kenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme , Kilifi, Kenya Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kelvin M. Kimenyi 1 Kenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme , Kilifi, Kenya 2 Department of Biochemistry, University of Nairobi , Nairobi, Kenya Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Kelvin M. Kimenyi Cavin Mgawe 1 Kenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme , Kilifi, Kenya Find this author on Google Scholar Find this author on PubMed Search for this author on this site Leonard Ndwiga 1 Kenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme , Kilifi, Kenya Find this author on Google Scholar Find this author on PubMed Search for this author on this site L. Isabella Ochola-Oyier 1 Kenya Medical Research Institute (KEMRI) - Wellcome Trust Research Programme , Kilifi, Kenya Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for L. Isabella Ochola-Oyier For correspondence: liochola{at}kemri-wellcome.org Abstract Full Text Info/History Metrics Preview PDF Abstract Background Genotyping P. falciparum polymorphic merozoite genes to describe parasite genetic diversity and the complexity of malaria infections (COI) is routinely used to assess the effectiveness of malaria control interventions. They are also utilized in anti-malarial drug therapeutic efficacy studies (TES) to differentiate recrudescent parasites from new infections. However, these polymorphic genes are usually under selection. Therefore, neutral microsatellite markers are preferred as they are also easier to genotype. The current study investigated the genetic diversity and COI using the poly-α microsatellite marker to provide background information on circulating genotypes before its applied to TES in Kenya. Methodology Dried blood spot (DBS) samples were obtained from 93 participants from a TES in Busia County in 2016 and 92 participants from a malaria monitoring study conducted in Kilifi in 2020. Genotyping of the poly-α microsatellite was done by PCR, capillary electrophoresis and the fragment data analyzed using GeneMarker. Results About 96.7% and 87% of the samples from Busia and Kilifi, respectively, were successfully genotyped. The infections in Busia were mainly polyclonal (80%) with a significantly higher mean COI of 2.9 (p < 0.0001), while those in Kilifi were mostly monoclonal (52.5%) with a mean COI of 1.7. Despite on average a younger population and lower parasite density, both regions had similar expected heterozygosity ( He ) (Busia = 0.92; Kilifi = 0.90) while Busia recorded a slightly higher number of effective alleles (Ne) (Busia = 10.8; Kilifi = 9.3). Conclusion The poly-α microsatellite genotyping revealed high genetic diversity of malaria parasites in Busia and Kilifi. These findings define the genotypes (fragment sizes) observed in the two Kenyan populations, providing a proof of concept for the utility of poly-α in TES studies as a molecular correction tool and for the evaluation of the effectiveness of malaria interventions in Kenya. Introduction Malaria continues to be a major public health burden worldwide. Despite the scaled up global efforts in combatting the ongoing disease transmission, there was a rise in malaria cases in 2023 to about 263 million cases and fortunately a decline in deaths to 597,000 when compared to 2022 that were 249 million cases and 608,000 deaths ( WHO, 2024 ). Sub-Saharan Africa (SSA) is the most affected region with 95% of malaria cases and deaths being caused by Plasmodium falciparum ( WHO, 2024 ). In Kenya, about 75% of the population is at risk of malaria infections with the Western Kenya and Coastal regions recording the highest community prevalence of about 18.9% and 4.5%, respectively ( Kenya National Bureau of Statistics. Kenya Malaria Indicator Survey, 2020 ). Although the scale-up of control efforts has led to an improved coverage of interventions and reduced transmission, malaria is still problematic accounting for about 15% of the hospital visits in these regions ( President’s Malaria Initiative, 2024 ). Malarial control and eventual elimination are currently threatened by the presence of infections harboring numerous genetically distinct parasites, otherwise known as the complexity of infection (COI), and the presence of highly diverse P. falciparum parasites. The assessment of COI and genetic diversity of P. falciparum parasites is normally used to evaluate the impact of malaria control interventions as well as provide insights into parasite transmission dynamics ( Apinjoh et al ., 2019 ). The genetic diversity of the parasites emerges during the parasite life-cycle in the mosquito when genetic recombination occurs following the fusion of male and female gametes to form zygotes leading to the production of novel genotypes ( Walliker et al ., 1987 ; Li et al ., 2019 ). Whereas the presence of multiple infections per individual (COI) happens either due to bites from a single mosquito carrying multiple parasite strains/clones or exposure to multiple infectious mosquito bites each introducing a different strain otherwise known as a superinfection (Nkhoma et al ., 2020). For the parasite, the high genetic diversity improves its fitness to develop resistance to selective forces such as host immunity and drugs ( Bose et al., 2016 ; Clay and Rudolf, 2019 ). A high COI within the host may enhance the development of multi-strain specific immunity resulting in a reduction in clinical symptoms and a controlling of parasitemia (Smith et al ., 1999), while the high competition amongst the clones may increase gametocyte production and select for more virulent strains ( Sondo et al ., 2019 ), further complicating malaria control. Currently, there are tools available for use to characterize the genetic diversity and COI of P. falciparum populations. These include molecular genotyping of highly polymorphic antigenic markers such as merozoite surface protein ( msp ) 1 and 2, and glutamate rich protein ( glurp ) using gel or capillary electrophoresis ( Liljander et al ., 2009 ). Genotyping these markers is recommended in anti-malarial drug therapeutic efficacy studies (TES) to differentiate recrudescent parasites from new infections ( WHO, 2008 ). The analysis of msp1 and msp2 is tedious and complex by gel electrophoresis or GeneMarker, since they have 3 and 2 allelic family members, respectively and within each family there is extensive diversity based on the repeat regions under analysis. Thus, determining fragment sizes with accuracy requires extensive familiarity with the peak shapes and sizes, a clean and clear control panel and an understanding of the analytical settings. All this makes the fragment analysis pipeline complex. A potential alternative is the amplicon deep sequencing of apical membrane antigen ( ama ) 1 and other polymorphic markers with no repeat regions or shorter repeat regions, as well as whole genome sequencing techniques ( Zhong, Lo, et al ., 2018 ; Osborne et al ., 2021 ; Wamae et al ., 2022 ). Though the amplification methods and analytical pipelines require rigorous optimization of merozoite antigen markers that are subject to strong immune selection and are thus highly polymorphic, it provides a high-resolution quantitative method. The next-generation sequencing tools despite being highly sensitive in identifying minor genotypes especially in multiclonal infections, are still costly when the combination of reagents and run costs are considered in Africa ( Zhong, Koepfli, et al ., 2018 ). However, the use of these platforms is expanding across Africa that will enable a reduction in cost over time. Recently, the use of microsatellites, short tandem repeats of 2-6 bp found throughout the P. falciparum genome, markers to study the parasite population structure has gained prominence ( Touray et al ., 2020 ; Ishengoma et al ., 2024 ; Mwesigwa et al ., 2024 ). These markers are highly polymorphic, easily amplifiable in the lab and are considered selection neutral since they are not under immune pressure ( Schlötterer, 1998 ; Anderson et al ., 1999 ; Zhong, Koepfli, et al ., 2018 ). There are several microsatellites that are well characterized whose polymorphisms differ among parasite populations (Anderson et al ., 2000). Studies have revealed that Poly-α, TAI, PfpK2 and TA42 are some of the most polymorphic microsatellites amongst parasite populations in the region ( Gatei et al ., 2015 ; Nderu et al ., 2019 ; Touray et al ., 2020 ; Mwesigwa et al ., 2024 ). The World Health Organization (WHO) has also endorsed the use of these microsatellites to study parasite genetic diversity and has recommended that either Poly-α, Pfpk2 or TA1, should replace glutamate rich protein ( glurp) that is considered less polymorphic and underestimates parasite genetic diversity, in anti-malarial drug efficacy studies ( WHO, 2021 ). Currently, there is insufficient knowledge on the diversity of poly-α microsatellite marker among the diverse parasite populations in Kenya to provide a background to the circulating genotypes in the population as this marker is introduced as a TES PCR correction marker. Therefore, the genetic diversity and COI of P. falciparum clinical infections was assessed from febrile cases attending primary healthcare facilities in two Kenyan populations, i.e. Busia in the Western Kenya region and Kilifi in the Coastal region (and to the East of Kenya), by genotyping the poly-α microsatellite marker. Materials and Methods Study design This study used 93 Day 0 samples from Busia County (a high malaria transmission region) collected from a TES that was conducted between August and September 2016 (Nderu et al ., 2019) and 92 samples collected from a malaria monitoring study collecting dried blood spots (DBS) samples from microscopy and rapid diagnostic test (RDT) confirmed malaria cases that was conducted between December 2019 and February 2020 in Kilifi County (a moderate to high malaria transmission region). In the TES study, children between the age of 6 months to 14 years with confirmed malaria infection (by microscopy) were randomized to receive dihydroartemisinin- piperaquine (DP) or artemether-lumefantrine (AL). The parasite density ranged from 1,000 to 100,000 in Busia and 160 to 720,000 in Kilifi. Written informed consent was obtained from the guardians of the study participants prior to sample collection. Ethical approval was obtained from the Kenya Medical Research Institute’s (KEMRI) Scientific Ethics and Review Unit (SERU) under protocol number 3403 for the TES study and 2617 for the malaria monitoring study. DNA extraction Samples from the two locations were accessed from the biobank in May 2023. Parasite genomic DNA was extracted using QIAcube HT according to the manufacturer’s instructions for the Kilifi samples and by the Chelex extraction method for the Busia samples. DNA extraction by Chelex- saponin method was performed as follows: Each DBS was punched to two 2.5-mm discs with a sterile (absolute ethanol [96%] and a flame) puncher at the center and periphery and transferred to a 1.5mL Eppendorf tubes with sterile tweezers. The samples were lysed overnight using 1mL of 0.5% (w/v) saponinin/1X phosphate-buffered saline (PBS). Following saponin aspiration, the discs were incubated in 1mL 1X PBS at 4°C for 30 min; thereafter, 150mL of a solution of 6% (w/v) Chelex in DNase/RNase-free water was used to incubate the samples for 30 min at 97°C. At regular (10min) intervals, the samples were vortexed and centrifuged to maximize the elution of DNA. The plates were then centrifuged at 4,000 × g for 5 min, and 120μl of the DNA-containing solution was stored at −20°C for further analyses. Genotyping of samples A 15μl PCR assay was conducted to amplify the poly-A marker. Fluorescently labelled primers were used (forward, 5‘- AAAATATAGACGAACAGA-3‘; reverse, 5‘- ATCAGATAATTGTTGGTA -3’ FAM). The expected size range was 100 – 201 based on (Anderson et al ., 2000). The reaction mix included 7.5μl of (Promega, Catalogue number: M7505), 0.6μl each of forward and reverse primers, 7.5μl nuclease-free water and 2μl of template DNA. Cycling conditions were as follows: initial denaturation at 94°C for 2 min, followed by 25 cycles of denaturation at 94°C for 20 sec, annealing at 45°C for 20 sec, extension at 65°C for 30 sec, and a final extension at 65°C for 2 min. The PCR products were visualized on 1.5% (w/v) agarose gel electrophoresis (Sigma-Aldrich, USA) in 0.5X TBE buffer. After staining with Redsafe® (iNtRON Biotechnology, Korea), the fragments were visualized under UV light using a Universal Hood II (Bio-Rad Laboratories, Inc., USA). Fragment sizes were estimated by comparison to a 100 base-pair DNA ladder (Promega, USA). About 1.5μl of the successfully amplified samples were mixed with 9 μl of Hi-Di formamide, and 0.5μl of size standard (ROX-350, Applied Biosystems). The solutions were transferred to 96-well Optical reaction plates and sent to the International Livestock Research Institute (ILRI) in Nairobi, Kenya, for capillary electrophoresis on the 3730xl DNA sequencer (Applied Biosystems). Fragment data analysis Analysis of the chromatograms was carried out using GeneMarker™ software version 3.0.1 (SoftGenetics). A panel was first created based on poly-α microsatellite size range that was adopted from (Anderson et al ., 2000). A relative fluorescence unit (RFU) threshold of 1000, based on the negative control, was used to distinguish true peaks from background noise and non-specific peaks. Major peaks above the RFU threshold and minor alleles with at least 30% of the major allele’s height were also scored. All chromatograms were manually reviewed to confirm the peaks. Fragment sizes were binned into 3 nucleotide windows. Since P. falciparum parasites are usually haploid, each genotype detected represented a distinct clone of the parasite. Consequently, the number of clones per individual infection in each population was defined as the complexity of infection (COI). The mean COI per population was calculated by dividing the total number of genotypes detected by the number of samples in that population. Mann–Whitney U test was used to compare continuous variables, i.e., COI, parasitemia and age, between the two populations, a p- value less than 0.05 was considered statistically significant. Isolates were categorized as monoclonal if they had a single genotype and polyclonal if they had at least two genotypes. For polyclonal samples, only the major genotype was used in the analyses of the expected heterozygosity ( He ). The He was described as the probability that two genotypes selected at random from a population will contain different alleles and ranges from 0 (no allele diversity) to 1 (all alleles are different). He was used to estimate poly-α allelic diversity at each location based on the formula below. where n is the sample size and P i is the frequency of i th allele in the population ( Nei, 1978 ). The metadata for the samples was accessed on 30 th May 2023 for the Kilifi samples and 30 th October 2024 for the Busia samples. Data analysis was performed using R version 4.4.2 (R Core Team, 2023) and graphical outputs generated using ggplot2 (version 3.5.1) package ( Kassambara, 2020 ). Results Characteristics of study participants Among the 93 samples screened in Busia in 2016, 86 had patient data while in Kilifi in 2020, 71 samples had patient data out of 92 samples. The participants from Busia were primarily female (53%) while those from Kilifi were mainly male (61%). Participants from Kilifi (median age = 5.3; IQR 3.0 – 8.3) were older than those from Busia (median = 3.8; IQR= 2.0 – 6.2). This age difference was statistically significant, P = 0.0174. The Kilifi participants also harbored significantly higher infections with a significantly high median parasitemia of150,000 (IQR: 7120, 265,000.0) compared to Busia median = 22,963 (IQR: 5,680.0, 37,480.0) based on microscopy ( P =0.001). Complexity of P. falciparum infections (COI) In malaria endemic regions, individuals often carry multiple genetically distinct parasite clones otherwise known as complexity of infection (COI). Individuals with one poly-α genotype were categorized as monoclonal, while those with more than one genotype were referred to as polyclonal. The majority of individuals in Busia had a high mean COI of 2.9 compared to Kilifi, COI = 1.7 ( Figure 1A ) this difference was statistically significant (p < 0.0001). Similarly, 80% of the infections in Busia were polyclonal, while in Kilifi these infections were lower at 47.5% ( Figure 1B ), with the highest number of clones per infection being 7 and 4, respectively. Download figure Open in new tab Figure 1: Complexity of infection (COI) across the two locations. A) Distribution of COI in Busia and Kilifi. The mean COi is depicted by the red dot and the red vertical line shows one standard deviation away from the mean. B) Proportion ofsrunples with genetically distinct genotypes detected in the uvo locations. The different colors represent the different number ofclones as sho,vn in the key. Genetic diversity of P. falciparum infections based on poly-α A total of 31 poly-α genotypes were reported from the two populations that ranged in size from 103bp to 210bp. Nineteen of these genotypes were prevalent in both locations, while five genotypes (102bp, 105bp, 111bp, 114bp and 195bp) were exclusively reported in Kilifi and seven genotypes (108bp, 126bp, 138bp, 177bp, 180bp, 186bp and 189bp) were exclusively reported in Busia. About 26 distinct genotypes (Na) were revealed from the 90 isolates that were successfully genotyped from Busia. These genotypes ranged in size from 103 to 210bp. The number of effective alleles (Ne) was 16.1 ( Table 2 ). The most common genotypes from Busia were 150bp, 153bp and 156bp that recorded frequencies of 11.2%, 9.6% and 10.8%, respectively ( Figure 2 ). In Kilifi, 24 distinct genotypes, ranging in size from 102 to 210bp, were revealed from the 80 successfully genotyped samples ( Table 2 ). Out of these, the three most common genotypes were 150bp, 153bp and 210bp whose frequencies were 14.4%, 18.7% and 11.5%, respectively ( Figure 2 ). The 156bp fragment was the 4 th common genotype in Kilifi. The 210bp fragment is unique with a very high frequency in the Kilifi population. In both populations, Ne (Busia = 10.8; Kilifi = 9.3), that represents the number of unique genotypes that would need to be equally frequent to achieve the same level of genetic diversity, was lower than Na indicating that majority of the genotypes occurred at low frequencies. The He , was similar in Busia (0.92) and Kilifi (0.9) ( Table 2 ). Download figure Open in new tab Figure 2: Frequencies of poly α alleles in Busia (black) and Kilifi (gray). The horizontal axis shows the individuals alleles sizes in base pairs (bp), vhile the vertical axis shows their respective frequences in percentage. Discussion The poly-α microsatellite genotyping revealed infections with high polyclonality and mean COI in Busia compared to Kilifi in low parasitemia infections, which could be attributed to the higher transmission intensity in Busia and the younger population sampled. This is consistent with other studies conducted in these regions revealing polyclonality levels between 75% - 80% in Western Kenya (Nderu et al ., 2019; Touray et al ., 2020) and 40% - 50% in Coastal Kenya (Nderu et al ., 2019; Kimenyi et al ., 2022) using microsatellites and other polymorphic markers. A high COI of 2.9 in Busia and 1.7 in Kilifi is also comparable to other studies in these regions that reported a mean COI of 3.4 in Mbita, Western Kenya (Touray et al ., 2020) and 1.6 in Msambweni, Coastal Kenya (Nderu et al ., 2019). The average parasite density in Busia was almost six-fold lower than Kilifi alluding to a high anti-disease immunity in the older population in Kilifi who would have experienced multiple malaria exposures. Thus, to experience malaria symptoms a higher parasite burden is required to overcome the developed malaria immunity over time. The high polyclonality of infections is further corroborated by the higher He in Busia complemented by the higher total number of genotypes, that is expected from a high transmission region. Other studies that have characterized the poly-α microsatellite marker have also revealed almost similar findings i.e. Mbita ( He = 0.95) (Touray et al ., 2020), Busia (0.92), Nyando (0.88) (Nderu et al ., 2019), Asembo ( He = 0.91) and Gem ( He = 0.89) (Gatei et al ., 2015) in Western Kenya and Msambweni ( He = 0.85) in Coastal Kenya (Nderu et al ., 2019). The high genetic diversity in Western Kenya may also be attributed to importation of diverse parasite strains from neighboring malaria endemic areas (Mulenge et al ., 2016). Thus, elucidating the impact of malaria control interventions using information from parasite genetic diversity studies should account for external factors impacting parasite population genetics. The most common poly-α genotypes included the 150 bp and 153 bp genotypes in Busia and Kilifi, respectively. In 2019, a Kenyan study reported that the 153 bp genotype was the most prevalent in Busia and Nyando while the 171 bp genotype was the most prevalent in Msambweni (Nderu et al ., 2019). Likewise, a study in Uganda has recently reported that the 153 bp genotype was the most prevalent among asymptomatic, uncomplicated and complicated malaria infections (Mwesigwa et al ., 2024). The 210bp fragment is unique with a high frequency in the Kilifi population, based on the assessment of the fragment sizes in GeneMarker it appears to be a true fragemnt that requires further validation in future studies. The analysis of poly-α was simple since it does not have any allelic family members and a shorter repeat region while still having the capability to define COI and several alleles within and between populations. This study based its findings on one microsatellite marker which may underestimate the parasite genetic diversity as it may fail to capture the entire genome-wide genetic diversity. Thus, the use of several microsatellite markers is recommended. However, it will require an analytical algorithm to determine with high accuracy the diversity in the population. Furthermore, it has been shown that genotypes/fragments may converge to similar sizes while not having identical sequence composition (Takala et al ., 2006), leading to underestimation of diversity. Thus, sequencing provides a higher resolution approach to decipher genetic diversity. The amplicon next-generation sequencing approach provides both qualitative and quantitative data to assess parasite population genetic diversity at high resolution to better determine COI (Lerch et al ., 2017). Though there are differences in the timing of samples collections and geographical locations, any genetic differences could be due to either time or geography. For example, the 210 bp fragment observed primarily in Kilifi compared to Busia would require additional sampling from the same time points from other regions in the country to resolve the differences observed. Nevertheless, the poly-α data provided a representation for circulating fragments sizes in Kenya and as a single marker indicated much lower malaria transmission in Kilifi compared to Busia based on the lower COI and more than half the infections being monoclonal. It is thus capable of distinguishing new from recrudescent infections in TES in addition to other polymorphic markers. Author Contributions LIO conceptualized the study, NA, conducted the assays, LN, LIO and NA optimized the data analysis pipeline, CM, NA, LN and KMK conducted the analysis and NA, KMK and LIO drafted the manuscript. All authors contributed and reviewed the final manuscript. Funding CM, KMK, LN, LIO and NA are grateful for the support of the Wellcome Trust to the Kenya Major Overseas Programme (number 203077). CM, KMK, NA and LIO, are supported by a Calestous Juma Leadership Fellowship, funded by BMGF (INV-036442). Data Availability The datasets supporting the conclusion of this article are available in the Harvard Dataverse repository: https://doi.org/10.7910/DVN/DAHYSD . Acknowledgements We thank the study participants as well as their parents/guardians for giving consent. We also extend our gratitude to Naomi Lucchi from the President’s Malaria Initiative (PMI) in Rwanda for her training on the poly-α PCR assay. This manuscript was written with the permission of Director KEMRI CGMRC. References ↵ Anderson , T.J.C. et al. ( 1999 ) ‘Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples’ , Parasitology , 119 ( 2 ), pp. 113 – 125 . OpenUrl CrossRef PubMed Web of Science Anderson , T.J.C. et al. ( 2000 ) ‘Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum’ , Molecular Biology and Evolution , 17 ( 10 ), pp. 1467 – 1482 . OpenUrl CrossRef PubMed Web of Science ↵ Apinjoh , T.O. et al. ( 2019 ) ‘Genetic diversity and drug resistance surveillance of Plasmodium falciparum for malaria elimination: is there an ideal tool for resource-limited sub-Saharan Africa?’ , Malaria Journal , 18 ( 1 ), p. 217 . OpenUrl CrossRef PubMed ↵ Bose , J. , Kloesener , M.H. and Schulte , R.D. ( 2016 ) ‘Multiple-genotype infections and their complex effect on virulence’ , Zoology , 119 ( 4 ), pp. 339 – 349 . OpenUrl CrossRef PubMed ↵ Clay , P.A. and Rudolf , V.H.W. ( 2019 ) ‘How parasite interaction strategies alter virulence evolution in multi-parasite communities’ , Evolution; international journal of organic evolution , 73 ( 11 ), pp. 2189 – 2203 . OpenUrl CrossRef PubMed ↵ Gatei , W. et al. ( 2015 ) ‘Genetic diversity of Plasmodium falciparum parasite by microsatellite markers after scale-up of insecticide-treated bed nets in western Kenya’ , Malaria Journal , 14 ( 1 ), p. 495 . OpenUrl CrossRef ↵ Ishengoma , D.S. et al. ( 2024 ) ‘Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania’ , Malaria Journal , 23 , p. 79 . OpenUrl CrossRef PubMed ↵ Kassambara , A. ( 2020 ) ‘“ggplot2” Based Publication Ready Plots. R package’. Comprehensive R Archive Network (CRAN) . Available at: https://cran.r-project.org/package=ggpubr (Accessed: 22 November 2021 ). Kenya National Bureau of Statistics . Kenya Malaria Indicator Survey 2020 . ( 2020 ). Nairobi, Kenya. Kimenyi , K.M. et al. ( 2022 ) ‘Maintenance of high temporal Plasmodium falciparum genetic diversity and complexity of infection in asymptomatic and symptomatic infections in Kilifi, Kenya from 2007 to 2018’ , Malaria Journal 2022 21:1 , 21 ( 1 ), pp. 1 – 10 . OpenUrl CrossRef PubMed Lerch , A. et al. ( 2017 ) ‘Development of amplicon deep sequencing markers and data analysis pipeline for genotyping multi-clonal malaria infections’ , BMC Genomics , 18 ( 1 ), p. 864 . OpenUrl CrossRef PubMed ↵ Li , X. et al. ( 2019 ) ‘Genetic mapping of fitness determinants across the malaria parasite Plasmodium falciparum life cycle’ , PLOS Genetics , 15 ( 10 ), p. e1008453 . OpenUrl CrossRef ↵ Liljander , A. et al. ( 2009 ) ‘Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2)’ , Malaria Journal , 8 ( 1 ), p. 78 . OpenUrl CrossRef PubMed Mulenge , F.M. et al. ( 2016 ) ‘Genetic diversity and population structure of plasmodium falciparum in lake victoria islands, a region of intense transmission’ , American Journal of Tropical Medicine and Hygiene , 95 ( 5 ), pp. 1077 – 1085 . OpenUrl Abstract / FREE Full Text ↵ Mwesigwa , A. et al. ( 2024 ) ‘Plasmodium falciparum genetic diversity and multiplicity of infection among asymptomatic and symptomatic malaria - infected individuals in Uganda’ , Tropical Medicine and Health , 7 . ↵ Nderu , D. et al. ( 2019 ) ‘Genetic diversity and population structure of Plasmodium falciparum in Kenyan–Ugandan border areas’ , Tropical Medicine & International Health , 24 ( 5 ), pp. 647 – 656 . OpenUrl CrossRef PubMed ↵ Nei , M. ( 1978 ) ‘Estimation of average heterozygosity and genetic distance from a small number of individuals’ , Genetics , 89 ( 3 ), pp. 583 – 590 . OpenUrl Abstract / FREE Full Text Nkhoma , S.C. et al. ( 2020 ) ‘Co-transmission of Related Malaria Parasite Lineages Shapes Within-Host Parasite Diversity’ , Cell Host and Microbe , 27 ( 1 ), pp. 93 - 103.e4 . OpenUrl CrossRef ↵ Osborne , A. et al. ( 2021 ) ‘Characterizing the genomic variation and population dynamics of Plasmodium falciparum malaria parasites in and around Lake Victoria, Kenya’ , Scientific Reports , 11 ( 1 ), p. 19809 . OpenUrl CrossRef PubMed ↵ President’s malaria initiative ( 2024 ) President malaria initiative Kenya . ↵ Schlötterer , C. ( 1998 ) ‘Genome evolution: Are microsatellites really simple sequences?’ , Current Biology , 8 ( 4 ), pp. R132 – R134 . OpenUrl CrossRef PubMed Web of Science Smith , T. et al. ( 1999 ) ‘Premunition in Plasmodium falciparum infection: insights from the epidemiology of multiple infections.’ , Transactions of the Royal Society of Tropical Medicine and Hygiene , 93 Suppl 1 , pp. 59 – 64 . OpenUrl CrossRef PubMed ↵ Sondo , P. et al. ( 2019 ) ‘Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans’ , Scientific Reports , 9 ( 1 ), p. 127 . OpenUrl CrossRef PubMed Takala , S.L. et al. ( 2006 ) ‘Genetic diversity in the Block 2 region of the merozoite surface protein 1 (MSP-1) of Plasmodium falciparum: Additional complexity and selection and convergence in fragment size polymorphism’ , Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases , 6 ( 5 ), p. 417 . OpenUrl CrossRef ↵ Touray , A.O. et al. ( 2020 ) ‘Diversity and multiplicity of P. falciparum infections among asymptomatic school children in Mbita, Western Kenya’ , Scientific Reports , 10 ( 1 ), p. 5924 . OpenUrl CrossRef PubMed ↵ Walliker , D. et al. ( 1987 ) ‘Genetic analysis of the human malaria parasite Plasmodium falciparum’ , Science (New York, N.Y .), 236 ( 4809 ), pp. 1661 – 1666 . OpenUrl CrossRef ↵ Wamae , K. et al. ( 2022 ) ‘Amplicon Sequencing as a Potential Surveillance Tool for Complexity of Infection and Drug Resistance Markers in Plasmodium falciparum Asymptomatic Infections’ , The Journal of Infectious Diseases [Preprint] . ↵ WHO ( 2008 ) ‘METHODS AND TECHNIQUES FOR CLINICAL TRIALS ON ANTIMALARIAL DRUG EFFICACY: genotyping to identify parasite populations’ , Geneva:World Health Organization [Preprint] . Available at: https://apps.who.int/iris/bitstream/handle/10665/43824/9789241596305_eng.pdf;jsessionid=A7E7E40F6753BE81D3C8CF7816E1B455?sequence=1 . ↵ WHO ( 2021 ) Informal consultation on methodoloty to distinguish reinfection from recrudenscence in high malaria transmission areas . Available at: https://apps.who.int/iris/rest/bitstreams/1389752/retrieve . ↵ WHO ( 2024 ) World malaria report 2024 . Available at: https://www.wipo.int/amc/en/mediation/ %0A https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023 . ↵ Zhong , D. , Koepfli , C. , et al. ( 2018 ) ‘Molecular approaches to determine the multiplicity of Plasmodium infections’ , Malaria Journal 2018 17:1 , 17 ( 1 ), pp. 1 – 9 . OpenUrl CrossRef PubMed Zhong , D. , Lo , E. , et al. ( 2018 ) ‘Multiplicity and molecular epidemiology of Plasmodium vivax and Plasmodium falciparum infections in East Africa’ , Malaria Journal , 17 ( 1 ), pp. 1 – 14 . OpenUrl CrossRef PubMed View the discussion thread. Back to top Previous Next Posted April 30, 2025. Download PDF Email Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Characterizing Plasmodium falciparum genetic diversity and complexity of infections in clinical malaria infections in Western and Coastal Kenya using the poly-alpha microsatellite marker Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Characterizing Plasmodium falciparum genetic diversity and complexity of infections in clinical malaria infections in Western and Coastal Kenya using the poly-alpha microsatellite marker Nicole Achieng’ , Kelvin M. Kimenyi , Cavin Mgawe , Leonard Ndwiga , L. Isabella Ochola-Oyier bioRxiv 2025.04.26.650801; doi: https://doi.org/10.1101/2025.04.26.650801 Share This Article: Copy Citation Tools Characterizing Plasmodium falciparum genetic diversity and complexity of infections in clinical malaria infections in Western and Coastal Kenya using the poly-alpha microsatellite marker Nicole Achieng’ , Kelvin M. Kimenyi , Cavin Mgawe , Leonard Ndwiga , L. Isabella Ochola-Oyier bioRxiv 2025.04.26.650801; doi: https://doi.org/10.1101/2025.04.26.650801 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Genetics Subject Areas All Articles Animal Behavior and Cognition (7629) Biochemistry (17660) Bioengineering (13881) Bioinformatics (41911) Biophysics (21436) Cancer Biology (18578) Cell Biology (25482) Clinical Trials (138) Developmental Biology (13371) Ecology (19887) Epidemiology (2067) Evolutionary Biology (24302) Genetics (15599) Genomics (22483) Immunology (17728) Microbiology (40364) Molecular Biology (17163) Neuroscience (88537) Paleontology (666) Pathology (2830) Pharmacology and Toxicology (4821) Physiology (7637) Plant Biology (15129) Scientific Communication and Education (2045) Synthetic Biology (4290) Systems Biology (9817) Zoology (2269)
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.